Belgium (BE)

Secondary resistance to sonidegib is rare in locally advanced basal cell carcinoma (2025) Muñoz Couselo E, Berking C, Baurain JF, Martelli S, Arntz R, Savoia P Journal article Outcompeting Thermodynamics: Ion-Pairing and Coulombic Interactions to Trigger Perfluoroacetate Intra-Ionic Photooxidation for Perfluoroalkylation Reactions (2025) Li P, Bourgois C, Glaser F, De Kreijger S, Cadranel A, Troian-Gautier L, Hu K Journal article s-Block Metal-Lanthanide Bonding: Direct Comparison of Mg-Yb and Mg-Ca Complexes (2025) Thakur SK, Roig N, Maurer J, Langer J, Alonso M, Harder S Journal article Biological and mechanical challenges in the endodontic treatment of immature teeth with pulp necrosis: insights based on a Series of Atypical Clinical Cases (2025) Leprince JG, Okamoto M, Widbiller M, Beauquis J, Pedano SM, Galler KM, Takahashi Y Journal article Preoperative breast MRI for invasive ductal carcinoma with or without a DCIS component at needle biopsy: influence on surgical outcomes in the MIPA study (2025) Cozzi A, Di Leo G, Houssami N, Gilbert FJ, Helbich TH, Álvarez Benito M, Balleyguier C, et al. Journal article Evaluating the maximal rate of lactate accumulation and estimated maximal lactate steady state in cycling (2025) Sablain M, Sperlich B, Meixner B, Caen K, Vermeire K, Boone J Journal article, Original article Pain Reduction in Linzagolix-Treated Patients With Uterine Fibroids: A Secondary Mediation Analysis of the PRIMROSE 1 and 2 Phase 3 Trials (2025) Becker S, Dolmans MM, Herrera FC, Petraglia F, Renner S, Ionescu-Ittu R, St-Pierre J, et al. Journal article Development and validation of a high-throughput screening pipeline of compound libraries to target EMT (2025) Jonckheere S, Taminau J, Adams J, Haerinck J, De Coninck J, Verstappe J, De Clercq K, et al. Journal article Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy (2025) Beniczky S, Trinka E, Wirrell E, Abdulla F, Al Baradie R, Alonso Vanegas M, Auvin S, et al. Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article